0000000000388334

AUTHOR

Piotr Feusette

0000-0002-5436-987x

showing 14 related works from this author

Letter by Sacha and Feusette Regarding Article, “Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing M…

2018

We have read with a great interest the article by Fernandez-Jimenez et al presenting a bimodal edematous reaction of reperfused myocardium after ST-segment elevation myocardial infarction (STEMI).1 According to the study, the initial edema emerges early and disappears by 24 hours; however, the second edema appears between days 4 and 7 after reperfusion. The authors conclude that the assessment of …

medicine.medical_specialtybusiness.industryHuman heart030204 cardiovascular system & hematologymedicine.diseaseArea at risk03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineEdemamedicineCardiologycardiovascular diseases030212 general & internal medicineMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Is It Time to Begin a Public Campaign Concerning Frailty and Pre-frailty? A Review Article

2017

Frailty is a state that encompasses losses in physical, psychological or social domains. Therefore, frail people demonstrate a reduced potential to manage external stressors and to respond to life incidents. Consequently, such persons are prone to various adverse consequences such as falls, cognitive decline, infections, hospitalisation, disability, institutionalisation and death. Pre-frailty is a condition predisposing and usually preceding the frailty state. Early detection of frailty (i.e., pre-frailty) may present an opportunity to introduce effective management to improve outcomes. Exercise training appears to be the basis of such management in addition to periodic monitoring of food i…

GerontologyWeaknessInstitutionalisationPhysiologyPsychological interventioncognitive frailtyReviewfrailtylcsh:Physiologysarcopenia03 medical and health sciences0302 clinical medicineWeight lossPhysiology (medical)exhaustionmedicineweakness030212 general & internal medicineCognitive declinelow physical activitylcsh:QP1-981business.industryStressormedicine.diseaseReview articlepre-frailtySarcopeniamedicine.symptomweight lossbusiness030217 neurology & neurosurgeryFrontiers in Physiology
researchProduct

Clinical manifestations of cancer in patients with acute pulmonary embolism

2023

Background Neoplasmatic disease increases the risk of acute pulmonary embolism (APE) by different pathophysiological mechanisms that favor thrombosis in patients with cancer. Recently, the role of cancer (active and occult) in the prevalence of venous thromboembolism has been discussed more thoroughly in the subject literature. Material Medical records of 366 consecutive patients with a diagnosis of APE (aged: mean = 65.0 ± 16.6, median = 68, range = 19–94; men = 41%/women = 59%) were collected with a wide range of demographic data, medical history of coexisting diseases, computer examination, and laboratory tests. Methods The APE patients were analyzed in two groups: negative cancer cases …

constant excess riskcancerGeneral MedicineCardiology and Cardiovascular Medicineacute pulmonary embolismlaboratory test differencesJournal of Cardiovascular Medicine
researchProduct

Real-Life Outcomes of Coronary Bifurcation Stenting in Acute Myocardial Infarction (Zabrze–Opole Registry)

2021

Percutaneous coronary intervention (PCI) of bifurcation lesions is a technical challenge associated with high risk of adverse events, especially in primary PCI. The aim of the study is to analyze long-term outcomes after PCI for coronary bifurcation in acute myocardial infarction (AMI). The outcome was defined as the rate of major adverse cardiac event related to target lesion failure (MACE-TLF) (death-TLF, nonfatal myocardial infarction-TLF and target lesion revascularization (TLR)) and the rate of stent thrombosis (ST). From 306 patients enrolled to the registry, 113 were diagnosed with AMI. In the long term, AMI was not a risk factor for MACE-TLF. The risk of MACE-TLF was dependent on th…

Target lesionmedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionCulpritArticlemedicine.arteryInternal medicinemedicineDiseases of the circulatory (Cardiovascular) systemPharmacology (medical)cardiovascular diseasesMyocardial infarctionGeneral Pharmacology Toxicology and PharmaceuticsRisk factoracute myocardial infarction; coronary bifurcation; percutaneous coronary intervention; target lesion failureAdverse effectcoronary bifurcationbusiness.industrypercutaneous coronary interventionPercutaneous coronary interventionmedicine.diseaseRC666-701Right coronary arteryConventional PCICardiologytarget lesion failurebusinessJournal of Cardiovascular Development and Disease
researchProduct

Comprehensive coordinated care after myocardial infarction (KOS-Zawał) : a patient's perspective

2019

AdultAged 80 and overmedicine.medical_specialtybusiness.industryPerspective (graphical)Myocardial InfarctionMiddle Agedmedicine.diseaseSurveys and QuestionnairesmedicineHumansComprehensive Health CarePolandMyocardial infarctionCardiology and Cardiovascular MedicineIntensive care medicinebusinessAged
researchProduct

MitraClip Implantation in Holography.

2021

Heart Valve Prosthesis ImplantationAugmented RealityTreatment OutcomeultrasoundHolographyMitraClipHumansMitral Valve InsufficiencyCardiology and Cardiovascular Medicinemixed realityJACC. Cardiovascular interventions
researchProduct

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

2019

Background: Appropriate antithrombotic regimens for patients with atrial fibrillation who have an acute coronary syndrome or have undergone percutaneous coronary intervention (PCI) are unclear. Methods: In an international trial with a two-by-two factorial design, we randomly assigned patients with atrial fibrillation who had an acute coronary syndrome or had undergone PCI and were planning to take a P2Y12 inhibitor to receive apixaban or a vitamin K antagonist and to receive aspirin or matching placebo for 6 months. The primary outcome was major or clinically relevant nonmajor bleeding. Secondary outcomes included death or hospitalization and a composite of ischemic events. Results: Enroll…

Malemedicine.medical_specialtyAcute coronary syndromeVitamin KPyridonesmedicine.medical_treatmentMEDLINEHemorrhage030204 cardiovascular system & hematologylaw.invention03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicinePharmacotherapyDouble-Blind MethodRandomized controlled triallawInternal medicineAtrial FibrillationAntithromboticmedicineHumans03.02. Klinikai orvostancardiovascular diseases030212 general & internal medicineAcute Coronary SyndromeAgedAged 80 and overAspirinbusiness.industryatrial fibrillation ; anticoagulant therapy ; acute coronary syndrome ; apixabanAnticoagulantsPercutaneous coronary interventionAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseConventional PCIPurinergic P2Y Receptor AntagonistsCardiologyPyrazolesDrug Therapy CombinationFemalebusinessPlatelet Aggregation InhibitorsFactor Xa InhibitorsNew England Journal of Medicine
researchProduct

The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function

2016

Background: Frequent premature ventricular complexes (PVC) are related to reversible tachycardia-induced cardiomyopathy. However, the role of arrhythmia burden on the outcome of the catheter ablation has not been fully recognised. Aim: The aim of this study was to assess the effect of catheter ablation and PVC burden in patients with and without structural heart disease (SHD) on left ventricular ejection fraction (LVEF). Methods: Transthoracic echocardiography was done before and six months after radiofrequency catheter ablation in 109 consecutive patients (61 men, age 55 ± 17 years) with frequent PVCs. Sixty-five (59.6%) patients had underlying SHD. Results: The catheter ablation procedure…

AdultMalemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentCardiomyopathyCatheter ablation030204 cardiovascular system & hematologyVentricular Dysfunction Left03 medical and health sciencesQRS complex0302 clinical medicineInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineventricular arrhythmiaAgedEjection fractionbusiness.industryleft ventricular ejection fractionStroke VolumeStroke volumeMiddle Agedmedicine.diseaseAblationstructural heart diseaseVentricular Premature ComplexesTreatment OutcomeEchocardiographyConcomitantMultivariate AnalysisCatheter Ablationcardiovascular systemCardiologyFemalepremature ventricular complexCardiology and Cardiovascular MedicinebusinessKardiologia Polska
researchProduct

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-…

2019

Contrast-induced nephropathy is a serious complication after intravascular administration of iodinated contrast media and is associated with numerous adverse outcomes. Its prevalence is particularly high in patients with multiple comorbidities who undergo coronary angiography and percutaneous coronary intervention (PCI). Currently, the only effective method to prevent contrast-induced kidney injury is adequate hydration and a reduction of contrast volume during the intervention. Recently, new approaches aiming to minimize contrast usage have been proposed, i.e., ultra-low contrast angiography and zero-contrast PCI. However, neither tutorials for these techniques nor reviews of their outcome…

medicine.medical_specialtyzero-contrast percutaneous coronary interventionmedia_common.quotation_subjectmedicine.medical_treatmentContrast-induced nephropathylcsh:Medicine030204 cardiovascular system & hematologyNephropathyrenal insufficiency03 medical and health sciences0302 clinical medicineIntervention (counseling)medicineContrast (vision)030212 general & internal medicineIntensive care medicinemedia_commonReview Paperbusiness.industrylcsh:RAcute kidney injuryPercutaneous coronary interventionmedicine.diseaseacute kidney injurycontrast-induced nephropathyConventional PCICardiology and Cardiovascular MedicinebusinessComplicationchronic kidney diseaseAdvances in Interventional Cardiology
researchProduct

Angiographic co-registration of instantaneous wave-free ratio and intravascular ultrasound improves functional assessment of borderline lesions in th…

2018

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryCo registration030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureText miningImage in InterventionIntravascular ultrasoundmedicineRadiologyInstantaneous wave-free ratioCardiology and Cardiovascular MedicinebusinessArteryPostępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
researchProduct

In-Hospital and One-Year Outcomes of Patients after Early and Late Resuscitated Cardiac Arrest Complicating Acute Myocardial Infarction—Data fr…

2022

The prognostic role of early (less than 48 h) resuscitated cardiac arrest (ErCA) complicating acute myocardial infarction (AMI) is still controversial. The present study aimed to analyse the short-term and one-year outcomes of patients after ErCA and late resuscitated cardiac arrest (LrCA) compared to patients without cardiac arrest (CA) complicating AMI. Data from the prospective nationwide Polish Registry of Acute Coronary Syndromes (PL-ACS) were used to assess patients with resuscitated cardiac arrest (rCA) after AMI. Baseline clinical characteristics and the predictors of all-cause death were assessed. The all-cause mortality rate, complications, performed procedures, and re-hospitalisa…

cardiac rehabilitationsecondary prevention of sudden cardiac deathdiabetes mellitus; ejection fraction; heart failure; myocardial infarctionlife-threatening ventricular arrhythmiaRMedicineacute coronary syndrome; cardiac rehabilitation; sudden cardiac death; life-threatening ventricular arrhythmia; early and late cardiac arrest; secondary prevention of sudden cardiac deathGeneral Medicineearly and late cardiac arrestsudden cardiac deathacute coronary syndromeJournal of Clinical Medicine; Volume 11; Issue 3; Pages: 609
researchProduct

Zero-contrast percutaneous coronary intervention of saphenous vein graft in a patient with chronic renal failure

2018

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedia_common.quotation_subjectSaphenous vein graftlcsh:RPercutaneous coronary interventionlcsh:MedicineText miningImage in InterventionInternal medicinemedicineCardiologyChronic renal failureContrast (vision)Cardiology and Cardiovascular Medicinebusinessmedia_commonAdvances in Interventional Cardiology
researchProduct

Does the origin of ablated premature ventricular contractions determine the level of left ventricular function improvement?

2020

Background: Premature ventricular contractions (PVCs) are associated with tachycardiomyopathy and high mortality rate. The treatment depends on the engaged ventricle. For PVCs originating from the right outflow tract (OT), radiofrequency catheter ablation (RFCA) is recommended (class IB‑R recommendation) in preference to pharmacotherapy. In those originating from the left ventricle, ablation is a class IIa B‑NR recommendation. Aims: The aim of the study was to assess the success of RFCA of PVCs based on arrhythmia origin. Methods: A total of 110 consecutive patients with monomorphic PVCs referred for ablation were enrolled and divided according to the site of ablation to the OT group and th…

medicine.medical_specialtymedicine.medical_treatmentHeart VentriclesCatheter ablationpremature ventricular contractionsVentricular Function LeftElectrocardiographyInterquartile rangeInternal medicinemedicineHumanstachycardiomyopathyAortic dissectionmedicine.diagnostic_testbusiness.industryMortality ratearrhythmia originOdds ratioAblationmedicine.diseaseVentricular Premature Complexesmedicine.anatomical_structureTreatment OutcomeVentricleCardiologyCatheter Ablationradiofrequency ablationCardiology and Cardiovascular MedicinebusinessElectrocardiographyKardiologia Polska
researchProduct

Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects

2019

Introduction Zero-contrast percutaneous coronary intervention (zero-PCI) is a new method for prevention of contrast-induced acute kidney injury (AKI) in patients with chronic kidney disease (CKD). However, evidence for its feasibility, safety and clinical utility is limited to reports of single cases or series of patients. Aim To present outcomes of zero-PCI in patients with severe CKD, including hemodialysis subjects, who were treated with this procedure in order to preserve their renal function. Material and methods Twenty-nine zero-PCIs were performed, mostly as a staged procedure, in 20 patients with advanced CKD. In this group, 4 patients were treated with hemodialysis but presented pr…

medicine.medical_specialtyzero-contrast percutaneous coronary interventionmedicine.medical_treatmentContrast-induced nephropathylcsh:MedicineRenal function030204 cardiovascular system & hematologyRevascularizationurologic and male genital diseasesrenal insufficiency03 medical and health sciences0302 clinical medicine0502 economics and businessmedicineRenal replacement therapyOriginal Paperbusiness.industrylcsh:R05 social sciencesAcute kidney injuryPercutaneous coronary interventionmedicine.diseaseSurgeryacute kidney injurycontrast-induced nephropathy050211 marketingHemodialysisCardiology and Cardiovascular MedicinebusinessKidney diseasePostępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
researchProduct